This document was written with the intent to be a complete reference at the time of
publication on the topic of managing hypertension in the elderly. Given the length of the …

Background: Beta-adrenergic receptors are expressed in cardiomyocytes and activated by
either noradrenaline released from sympathetic synapses or circulating catecholamines …

Nebivolol is a highly selective β 1-adrenergic receptor antagonist with a pharmacologic
profile that differs from those of other drugs in its class. In addition to cardioselectivity …

Beta blockers have been used in the treatment of cardiovascular conditions for decades.
Despite a long history and status as a guideline-recommended treatment option for …

Nebivolol (Bystolic®) is a cardioselective beta 1 (β1)‐adrenergic receptor blocker with
endothelium‐dependent vasodilating properties. The endothelium‐dependent relaxation …

Nebivolol is a third-generation β-adrenergic receptor antagonist (β-blocker) with high
selectivity for β 1-adrenergic receptors. In addition, it causes vasodilatation via interaction …

Background Beta blockers are commonly used to treat hypertension. The blood pressure
reading is the primary tool for physicians and patients to assess the efficacy of the treatment …

Hypertension is an asymptomatic condition of persistently elevated blood pressure (BP) that
affects approximately 50 million Americans and one billion people worldwide. 1, 2 It has …

Materials and Methods: In this single arm, open-labeled study, 13 patients were given
nebivolol, 5 mg orally once daily for 15 days. Primary outcome was change in central aortic …

Hypertension is often treated pharmacologically. Since there is evidence that the
cardiovascular system is sensitive to placebo mechanisms, our aim was to conduct an effect …